Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,071
  • Shares Outstanding, K 8,358
  • Annual Sales, $ 4,140 K
  • Annual Income, $ -7,950 K
  • 60-Month Beta 0.29
  • Price/Sales 0.27
  • Price/Cash Flow N/A
  • Price/Book 0.15
Trade INM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.13
  • Most Recent Earnings $-0.18 on 05/14/24
  • Next Earnings Date 05/20/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2122 +19.46%
on 06/17/24
0.3175 -20.16%
on 06/05/24
-0.0518 (-16.97%)
since 06/03/24
3-Month
0.2122 +19.46%
on 06/17/24
0.4555 -44.35%
on 04/04/24
-0.0965 (-27.57%)
since 04/03/24
52-Week
0.2122 +19.46%
on 06/17/24
2.0800 -87.81%
on 10/24/23
-0.6665 (-72.45%)
since 07/03/23

Most Recent Stories

More News
InMed Pharmaceuticals (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases

InMed Pharmaceuticals (NASDAQ: INM), a is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s...

AMD : 163.90 (-0.25%)
INM : 0.2535 (+2.30%)
InMed Pharmaceuticals (NASDAQ: INM) Announces Participation at Emerging Growth Conference

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, will be featured in this week’s Emerging Growth...

INM : 0.2535 (+2.30%)
InMed to Present at the Emerging Growth Conference

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a clinical stage pharmaceutical company focused on developing a pipeline...

INM : 0.2535 (+2.30%)
InMed Pharmaceuticals (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial Results

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, is reporting on its financial and business results...

INM : 0.2535 (+2.30%)
InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

Reported positive preclinical data in both its Alzheimer's and dry AMD programsClosed Fiscal Q3 with cash position of US$7.9 millionVancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - InMed...

INM : 0.2535 (+2.30%)
InMed (NASDAQ: INM) Welcomes Leading Authority in Alzheimer’s Research to Scientific Advisory Board

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is announcing that Dr. David G. Morgan, PhD,...

INM : 0.2535 (+2.30%)
InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board

Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the research, development, manufacturing, and commercialization...

INM : 0.2535 (+2.30%)
InMed (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical...

AMD : 163.90 (-0.25%)
INM : 0.2535 (+2.30%)
InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration

Small molecule drug acting as a preferential signaling ligand for CB1/CB2 Delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement in in vivo preclinical disease...

INM : 0.2535 (+2.30%)
InMed Pharmaceuticals (NASDAQ: INM) Releases Favorable Results from INM-901 Preclinical AD Studies

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting additional preclinical data...

INM : 0.2535 (+2.30%)

Business Summary

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.

See More

Key Turning Points

3rd Resistance Point 0.2795
2nd Resistance Point 0.2712
1st Resistance Point 0.2623
Last Price 0.2535
1st Support Level 0.2451
2nd Support Level 0.2368
3rd Support Level 0.2279

See More

52-Week High 2.0800
Fibonacci 61.8% 1.3665
Fibonacci 50% 1.1461
Fibonacci 38.2% 0.9257
Last Price 0.2535
52-Week Low 0.2122

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar